THE EFFECT OF SHORT VERSUS LONG EXPOSURE TIMES OF ARGON-LASER PANRETINAL PHOTOCOAGULATION ON PROLIFERATIVE DIABETIC-RETINOPATHY

被引:7
|
作者
WADE, EC [1 ]
BLANKENSHIP, GW [1 ]
机构
[1] UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,DEPT OPHTHALMOL,MIAMI,FL 33152
关键词
D O I
10.1007/BF00920025
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We performed a randomized clinical trial comparing short-duration (0.1 s) with long-duration (0.5 s) bluegreen argon laser burns to deliver panretinal photocoagulation (PRP) in eyes suffering from proliferative diabetic retinopathy with high risk characteristics. We studied 19 eyes in the 0.1-s group and 24 eyes in the 0.5-s group for 6 months. Two or more lines of acuity were lost by 20% of the 0.1-s PRP eyes, but by only 8% of the 0.5-s PRP eyes; New or increased vitreous hemorrhages occurred in 30% of the 0.1-s PRP eyes, but in only 16% of the 0.5-s PRP eyes; New or increased traction retinal detachments did not occur in the 0.1-s PRP eyes, but occurred in 16% of the 0.5-s PRP eyes. There was complete disc neovascular regression in 85% of the 0.1-s PRP eyes and 81% of the 0.5-s PRP eyes. These trends were not statistically significant. © 1990 Springer-Verlag.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [41] Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy
    Bandello, F
    Polito, A
    Pognuz, DR
    Monaco, P
    Dimastrogiovanni, A
    Paissios, J
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (05) : 643 - 650
  • [42] RED KRYPTON AND BLUE-GREEN ARGON-LASER DIABETIC PANRETINAL PHOTOCOAGULATION
    BLANKENSHIP, GW
    GERKE, E
    BATLLE, JF
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1989, 227 (04) : 364 - 368
  • [43] CENTRAL VISUAL-FIELD CHANGES AFTER PANRETINAL PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC-RETINOPATHY
    THEODOSSIADIS, GP
    BOUDOURI, A
    GEORGOPOULOS, G
    KOUTSANDREA, C
    OPHTHALMOLOGICA, 1990, 201 (02) : 71 - 78
  • [44] Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy
    Zhou, Ai-Yi
    Zhou, Chen-Jing
    Yao, Jing
    Quan, Yan-Long
    Ren, Bai-Chao
    Wang, Jian-Ming
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (12) : 1772 - 1778
  • [45] ARGON-LASER V-XENON ARC PHOTO-COAGULATION IN PROLIFERATIVE DIABETIC-RETINOPATHY
    CRICK, MDP
    CHIGNELL, AH
    SHILLING, JS
    TRANSACTIONS OF THE OPHTHALMOLOGICAL SOCIETIES OF THE UNITED KINGDOM, 1978, 98 (APR): : 170 - 171
  • [46] Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study
    Lang, Gabriele E.
    Stahl, Andreas
    Voegeler, Jessica
    Quiering, Claudia
    Lorenz, Katrin
    Spital, Georg
    Liakopoulos, Sandra
    ACTA OPHTHALMOLOGICA, 2020, 98 (05) : E530 - E539
  • [48] Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser
    Alasil, Tarek
    Waheed, Nadia K.
    CURRENT OPINION IN OPHTHALMOLOGY, 2014, 25 (03) : 164 - 170
  • [49] COLOR CONTRAST SENSITIVITY AND PATTERN ELECTRORETINOGRAPHIC FINDINGS AFTER DIODE AND ARGON-LASER PHOTOCOAGULATION IN DIABETIC-RETINOPATHY
    ULBIG, MRW
    ARDEN, GB
    HAMILTON, AMP
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (05) : 583 - 588
  • [50] Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
    Lin, James
    Chang, Jonathan S.
    Smiddy, William E.
    OPHTHALMOLOGY, 2016, 123 (09) : 1912 - 1918